Viking Systems, Inc. (VKNG.OB) 3DHD Visualization System Selected for Soon to be Demonstrated Alternative Surgical Robotic System

QualityStocks would like to highlight Viking Systems (OTCBB: VKNG), a global developer and marketer of 2D and 3D invasive surgery applicable solutions.

In the company’s news yesterday,

Viking Systems reported selection of the company’s 3DHD system for the vision component in a new surgical robotic system to be demonstrated at the upcoming (Mar. 18-22) European Association of Urology (EAU) Annual Meeting in Vienna.

This alternative surgical robotic system is designed to be cost-effective while incorporating many of today’s most innovative technologies, like the ETHOS Ergonomic Surgical Platform™ (Ethos Surgical) and Kymerax Articulating Surgical instruments (Terumo Corp.), in addition to the Company’s 3DHD system.

President and CEO of VKNG, Jed Kennedy, welcomed this major opportunity to realize a key component of the Company’s overall growth strategy, namely the exploration of new ways to incorporate/integrate existing proprietary technologies into emergent surgical robotics.

Kennedy greeted this chance to broaden the market for the 3DHD system while working with trusted collaborators like Terumo and Ethos to help meet the growing demand from surgeons for precisely such an alternative to the costly surgical robotic systems on the market today.

The fusion of these three key technologies into one platform where they can be used independently or in conjunction, realizes the three primary tasks associated with robotic surgery at significantly reduced cost:

• Easily interpretable 3D view of the laparoscopic surgical field
• Precision control of instruments
• Comfortable and ergonomically ideal operating position for the surgeon

Founder and CEO of Ethos, Craig Turner, MD, called the system a real breakthrough for laparoscopic operative practices that would allow surgeons the superior performance capabilities that go along with being able to easily and readily manipulate instruments from a comfortable position.

General Manager at Terumo Europe N.V.’s TRAM Business Unit, Masao Hitotsuyanagi, called the marriage of these technologies a powerful demonstration of the true potential of next-generation surgical robotic systems.

The Viking 3DHD Visualization System really has made a name for itself since its launch in October of 2010, as uptake throughout distributor channels provided opportunities to demonstrate how effective the free-standing 3D vision systems can be.

The ability to easily integrate the system with emergent surgical robotics platforms and handheld surgical equipment or other medical devices means that VKNG has plenty of venues to take the technology down, and the Company is fiercely pursuing any and all methods for expanding the 3DHD market.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.